New Requirement - hydrogen generator

The Food and Drug Administration (FDA) has issued a forecast for the acquisition of one hydrogen generator, under the NAICS code 334516 which corresponds to instruments and related products manufacturing. This upcoming requirement is intended to support the agency's operational needs, although specific details such as the solicitation number, set-aside information, and precise location of performance have not been provided at this stage. The contract is currently in its forecast phase as of March 11, 2026, signaling an anticipated procurement opportunity. Key contacts include the FDA's Acquisition Liaison, who can be reached via email, with the contracting officer position yet to be assigned. Interested parties may obtain further information or track updates through the designated online portal linked to the FDA’s industry opportunity forecast. This contract is aimed at equipping the agency with essential hydrogen generation capability, presumably to support research, testing, or manufacturing processes within the FDA's purview.